UK Device Regulatory System Off To Good Start Under ‘Supportive’ MHRA
The UK’s new medical device registration system, one element of the post-Brexit transition being overseen by the MHRA, is going more or less to plan in the early stages of the standstill period.
You may also be interested in...
Evolving health care demands, digital innovation and the need to work within tighter budgets have prompted the UK’s NICE to reset its strategy for the coming five years.
The duties of the new commissioner for patient safety have been prioritized in the UK’s Medicines and Medical Devices bill, which has been given Royal Assent.
The performances of the leading medtechs in the first year of the COVID pandemic were impossible to compare and certainly unrepresentative of normal business cycles and competitive activity. Elective care was largely put on hold and emergency needs boosted exceptional demand for certain product types. More than anything else, 2020 tested management's planning skills.